DK1098898T3 - Calcium-(3S)-tetrahydro-3-furanyl-(1S,2R)-3-[[(4-aminophenyl)-sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamat - Google Patents

Calcium-(3S)-tetrahydro-3-furanyl-(1S,2R)-3-[[(4-aminophenyl)-sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamat

Info

Publication number: DK1098898T3
Authority: DK; Denmark
Prior art keywords: propylcarbamate; phosphonooxy; aminophenyl; furanyl; tetrahydro
Prior art date: 1998-07-18

Application number

DK99934698T

Other languages

Danish (da)

English (en)

Inventor

Ian Gordon Armitage

Andrew David Searle

Hardev Singh

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-18

Filing date

1999-07-15

Publication date

2003-04-07

1999-07-15 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2003-04-07 Application granted granted Critical

2003-04-07 Publication of DK1098898T3 publication Critical patent/DK1098898T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Biochemistry (AREA)
Epidemiology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK99934698T 1998-07-18 1999-07-15 Calcium-(3S)-tetrahydro-3-furanyl-(1S,2R)-3-[[(4-aminophenyl)-sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamat DK1098898T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9815567.4A GB9815567D0 (en)	1998-07-18	1998-07-18	Antiviral compound
PCT/EP1999/004991 WO2000004033A1 (fr)	1998-07-18	1999-07-15	Calcium (3s) tetrahydro-3-furanyle (1s,2r)-3-[[(4-aminophenyle) sulfonyle] (isobutyle) amino]-1-benzyle-2-(phosphonooxy) propylcarbamate

Publications (1)

Publication Number	Publication Date
DK1098898T3 true DK1098898T3 (da)	2003-04-07

Family

ID=10835689

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99934698T DK1098898T3 (da)	1998-07-18	1999-07-15	Calcium-(3S)-tetrahydro-3-furanyl-(1S,2R)-3-[[(4-aminophenyl)-sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamat

Country Status (47)

Country	Link
US (3)	US6514953B1 (fr)
EP (2)	EP1098898B1 (fr)
JP (1)	JP3437553B2 (fr)
KR (1)	KR100694721B1 (fr)
CN (1)	CN1188422C (fr)
AP (1)	AP2001002039A0 (fr)
AR (1)	AR019388A1 (fr)
AT (1)	ATE229964T1 (fr)
AU (1)	AU766056B2 (fr)
BG (1)	BG105253A (fr)
BR (1)	BRPI9912156B8 (fr)
CA (1)	CA2337857C (fr)
CO (1)	CO5090836A1 (fr)
CZ (1)	CZ300447B6 (fr)
DE (1)	DE69904600T2 (fr)
DK (1)	DK1098898T3 (fr)
DZ (1)	DZ2845A1 (fr)
EA (1)	EA003191B1 (fr)
EE (1)	EE200100038A (fr)
ES (1)	ES2189450T3 (fr)
GB (1)	GB9815567D0 (fr)
GC (1)	GC0000105A (fr)
GE (1)	GEP20033030B (fr)
GT (1)	GT199900111A (fr)
HR (1)	HRP20010046A2 (fr)
HU (1)	HU229700B1 (fr)
ID (1)	ID28070A (fr)
IL (1)	IL140824A (fr)
IS (1)	IS5808A (fr)
JO (1)	JO2114B1 (fr)
MA (1)	MA26660A1 (fr)
MY (1)	MY122323A (fr)
NO (1)	NO329676B1 (fr)
NZ (1)	NZ509291A (fr)
OA (1)	OA11706A (fr)
PA (1)	PA8477801A1 (fr)
PE (1)	PE20000869A1 (fr)
PL (1)	PL195736B1 (fr)
PT (1)	PT1098898E (fr)
SK (1)	SK285311B6 (fr)
SV (1)	SV1999000096A (fr)
TN (1)	TNSN99145A1 (fr)
TR (1)	TR200100111T2 (fr)
TW (1)	TWI245770B (fr)
WO (1)	WO2000004033A1 (fr)
YU (1)	YU3401A (fr)
ZA (1)	ZA200100417B (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9914821D0 (en) *	1999-06-24	1999-08-25	Glaxo Group Ltd	Compounds
CZ300031B6 (cs) *	1999-10-06	2009-01-14	Tibotec Pharmaceuticals Ltd.	Hexahydrofuro[2,3-b]furan-3-yl-N-{3-[(1,3-benzodioxol-5-ylsulfonyl) (isobutyl)amino]-1-benzyl-2-hydroxypropyl}karbamát a farmaceutický prípravek s jeho obsahem
DE60017180T2 (de)	1999-10-08	2005-12-08	Affinium Pharmaceuticals, Inc., Toronto	Fab i inhibitoren
JP4387804B2 (ja) *	2001-04-06	2009-12-24	アフィニアム・ファーマシューティカルズ・インコーポレイテッド	ＦａｂＩ阻害剤
CN101074242A (zh) *	2002-04-26	2007-11-21	吉里德科学公司	Hiv蛋白酶抑制剂化合物的膦酸酯类似物的细胞蓄积及这类化合物
SI1575951T1 (sl) *	2002-12-06	2014-10-30	Debiopharm International Sa Forum "Apres-Demain"	Heterociklične spojine, postopki za njihovo izdelavo in njihova uporaba v terapiji
DE602004016831D1 (de)	2003-03-17	2008-11-13	Affinium Pharm Inc	Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
US7432261B2 (en)	2003-04-25	2008-10-07	Gilead Sciences, Inc.	Anti-inflammatory phosphonate compounds
US7407965B2 (en)	2003-04-25	2008-08-05	Gilead Sciences, Inc.	Phosphonate analogs for treating metabolic diseases
US7470724B2 (en)	2003-04-25	2008-12-30	Gilead Sciences, Inc.	Phosphonate compounds having immuno-modulatory activity
WO2005002626A2 (fr)	2003-04-25	2005-01-13	Gilead Sciences, Inc.	Composes de phosphonate therapeutiques
CA2523083C (fr)	2003-04-25	2014-07-08	Gilead Sciences, Inc.	Analogues de phosphonate antiviraux
WO2004096285A2 (fr)	2003-04-25	2004-11-11	Gilead Sciences, Inc.	Analogues anti-infectieux du phosphonate
KR20060022647A (ko)	2003-04-25	2006-03-10	길리애드 사이언시즈, 인코포레이티드	키나아제 억제 포스포네이트 유사체
US7427636B2 (en)	2003-04-25	2008-09-23	Gilead Sciences, Inc.	Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
WO2005047898A2 (fr)	2003-10-24	2005-05-26	Gilead Sciences, Inc.	Procedes et compositions pour l'identification des composes therapeutiques
US7452901B2 (en)	2003-04-25	2008-11-18	Gilead Sciences, Inc.	Anti-cancer phosphonate analogs
ES2297467T3 (es) *	2003-09-30	2008-05-01	Tibotec Pharmaceuticals Ltd.	Sulfonamidas de inhibicion de vhc.
US7427624B2 (en)	2003-10-24	2008-09-23	Gilead Sciences, Inc.	Purine nucleoside phosphorylase inhibitory phosphonate compounds
US7432273B2 (en)	2003-10-24	2008-10-07	Gilead Sciences, Inc.	Phosphonate analogs of antimetabolites
KR20060127906A (ko)	2003-12-22	2006-12-13	길리애드 사이언시즈, 인코포레이티드	4'-치환된 카보버와 아바카비어 유도체 및 ｈｉｖ와 ｈｃｖ항바이러스 활성을 갖는 관련 화합물
EP2848614A3 (fr) *	2004-06-04	2015-07-29	Debiopharm International SA	Dérivés de acrylamide et leur utilisation comme agents antibiotiques
AP2412A (en)	2004-07-27	2012-06-01	Gilead Sciences Inc	Phosphonate analogs of HIV inhibitor compounds.
EA018007B1 (ru)	2004-11-26	2013-04-30	Ю Си Эл БИЗНЕС Пи Эл Си	Композиция, содержащая орнитин и фенилацетат или фенилбутират, для лечения печеночной энцефалопатии
US20090156578A1 (en) *	2005-12-05	2009-06-18	PAULS Henry	3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
EP2687533B1 (fr)	2006-07-20	2017-07-19	Debiopharm International SA	Dérivés d'acrylamide en tant qu'inhibiteurs de FAB I
WO2008098374A1 (fr)	2007-02-16	2008-08-21	Affinium Pharmaceuticals, Inc.	Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
MX2009009850A (es)	2007-03-12	2009-09-24	Nektar Therapeutics	Conjugados de inhibidor de oligomero-proteasa.
EP2262538B1 (fr) *	2008-03-12	2014-12-10	Nektar Therapeutics	Conjugués oligomères-acides aminés
EP2307435B1 (fr)	2008-07-08	2012-06-13	Gilead Sciences, Inc.	Sels de composés inhibiteurs du vih
KR101975726B1 (ko)	2009-04-03	2019-05-07	오세라 테라퓨틱스, 아이엔씨.	Ｌ-오르니틴 페닐 아세테이트, 및 이의 제조방법
EP2432788A1 (fr) *	2009-05-20	2012-03-28	Ranbaxy Laboratories Limited	Fosamprenavir calcique amorphe
US20120157526A1 (en)	2009-06-08	2012-06-21	Ucl Business Plc	Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
EP2440249A2 (fr)	2009-06-12	2012-04-18	Nektar Therapeutics	Conjugués covalents comprenant un inhibiteurs de protéase, un oligomère non-peptidique soluble dans l'eau et une partie lipophilique
WO2011001383A1 (fr) *	2009-06-30	2011-01-06	Ranbaxy Laboratories Limited	Forme cristalline de fosamprénavir calcium
EP2477996A1 (fr) *	2009-09-16	2012-07-25	Ranbaxy Laboratories Limited	Procédé pour préparer du fosamprénavir calcium
WO2011085130A1 (fr) *	2010-01-07	2011-07-14	Pliva Hrvatska D.O.O.	Formes solides du sel de calcium du fosamprénavir et leur procédé de synthèse
LT3494972T (lt)	2010-01-27	2024-03-12	Viiv Healthcare Company	Dolutegraviro ir lamivudino kompozicija živ infekcijai gydyti
US20110224443A1 (en) *	2010-03-15	2011-09-15	Venkata Naga Brahmeshwara Rao Mandava	Preparation of fosamprenavir calcium
WO2011114212A1 (fr)	2010-03-19	2011-09-22	Lupin Limited	Sels d'ammonium, de calcium et de tris de fosamprénavir
US20130211108A1 (en) *	2010-06-18	2013-08-15	Mylan Laboratories Ltd	Novel process for the preparation of (3s)-tetrahydrofuran-3-yl (is, 2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate and its pharmaceutically acceptable salts
EP2614055A2 (fr)	2010-09-10	2013-07-17	Lupin Limited	Procédé de préparation de calcium de fosamprenavir sensiblement pur et de ses intermédiaires
CN103502203B (zh)	2010-10-06	2016-09-07	欧塞拉治疗有限公司	制备l-鸟氨酸苯基乙酸盐的方法
CN102453053B (zh) *	2010-10-29	2014-11-26	浙江九洲药业股份有限公司	一种福沙那韦钙晶体及其制备方法
CN102453054B (zh)	2010-10-29	2015-06-10	浙江九洲药业股份有限公司	一种福沙那韦衍生物的制备方法及相关中间体
WO2012085625A1 (fr)	2010-12-21	2012-06-28	Lupin Limited	Procédé pour la préparation de fosamprénavir calcique et d'un intermédiaire utilisé dans sa préparation
US8993786B2 (en)	2011-02-10	2015-03-31	Mylan Laboratories Ltd.	Crystalline fosamprenavir calcium and process for the preparation thereof
WO2013011485A1 (fr)	2011-07-20	2013-01-24	Ranbaxy Laboratories Limited	Procédé de préparation de sulfonamides utiles en tant qu'inhibiteurs de protéase rétroviraux
WO2013105118A1 (fr)	2012-01-10	2013-07-18	Council Of Scientific & Industrial Research	Procédé pour la synthèse d' azido-époxyde synthétique et son utilisation en tant qu'intermédiaire de la synthèse d'amprénavir et de saquinavir
LT2861608T (lt)	2012-06-19	2019-07-10	Debiopharm International Sa	(e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-nafthidrin-3-il)akrilamido provaisto dariniai
EP3685841A1 (fr)	2014-11-24	2020-07-29	Ucl Business Ltd	Traitement de maladies associées à l'activation de cellules hépatiques de kupffer utilisant des thérapies de réduction d'ammoniac
CA2995823A1 (fr)	2015-08-18	2017-02-23	Ocera Therapeutics, Inc.	Traitement et prevention de la perte musculaire au moyen de l-ornithine en combinaison avec au moins un parmi l'acetate de phenyle et le butyrate de phenyle
AU2017223037B2 (en)	2016-02-26	2022-04-14	Debiopharm International S.A.	Medicament for treatment of diabetic foot infections
WO2018208677A1 (fr)	2017-05-11	2018-11-15	Ocera Therapeutics, Inc.	Procédés de fabrication de l-ornithine phénylacétate
PL3661937T3 (pl)	2017-08-01	2021-12-20	Gilead Sciences, Inc.	Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych
CN116327781A (zh)	2019-02-14	2023-06-27	德彪药业国际股份公司	阿法比星制剂及其制备方法
MX2021015513A (es)	2019-06-14	2022-04-20	Debiopharm Int Sa	Medicamento y uso del mismo para tratar infecciones bacterianas que involucran una biopelicula.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2698826A (en) *	1951-02-13	1955-01-04	Merco Centrifugal Co	Alcohol manufacturing process
US3437267A (en) *	1966-03-24	1969-04-08	Alfa Laval Ab	Centrifuge
JPH0244315B2 (ja) *	1982-06-14	1990-10-03	Microbial Chem Res Found	Supagarinn155hosufueetooyobisonoseizoho
US5723490A (en)	1992-09-08	1998-03-03	Vertex Pharmaceuticals Incorporated	THF-containing sulfonamide inhibitors of aspartyl protease
UA49803C2 (uk) *	1994-06-03	2002-10-15	Дж.Д. Сьорль Енд Ко	Спосіб лікування ретровірусних інфекцій
BR9814484A (pt) *	1997-12-24	2000-10-10	Vertex Pharma	"pró-drogas de inibidores de aspartil protease"
AU2010299A (en) *	1997-12-24	1999-07-19	Vertex Pharmaceuticals Incorporated	Prodrugs os aspartyl protease inhibitors
US6436989B1 (en) *	1997-12-24	2002-08-20	Vertex Pharmaceuticals, Incorporated	Prodrugs of aspartyl protease inhibitors
GB9812189D0 (en) *	1998-06-05	1998-08-05	Glaxo Group Ltd	Methods and compositions for increasing penetration of HIV protease inhibitors
WO2000018384A2 (fr) *	1998-09-28	2000-04-06	Glaxo Group Limited	Combinaisons antivirales renfermant un ester isopropylique d'acide (s)-2-ethyl-7-fluoro-3-oxo-3,4-dihydro-2h-quinoxaline-1-carboxylique
WO2000025784A1 (fr) *	1998-11-04	2000-05-11	Pharmacia & Upjohn Company	Methode destinee a ameliorer la pharmacocinetique du tipranavir
CZ20002364A3 (cs) *	1998-12-23	2000-11-15	Vertex Pharmaceuticals Incorporated	Deriváty sulfonamidů a farmaceutický prostředek, který je obsahuje
GB9914821D0 (en) *	1999-06-24	1999-08-25	Glaxo Group Ltd	Compounds
ATE377011T1 (de) *	1999-11-24	2007-11-15	Merck & Co Inc	Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1- piperazinpentanamide als hiv-proteasehemmer

1998
- 1998-07-18 GB GBGB9815567.4A patent/GB9815567D0/en not_active Ceased
1999
- 1999-07-14 GC GCP1999203 patent/GC0000105A/xx active
- 1999-07-14 AR ARP990103446A patent/AR019388A1/es not_active Application Discontinuation
- 1999-07-14 DZ DZ990145A patent/DZ2845A1/fr active
- 1999-07-15 EE EEP200100038A patent/EE200100038A/xx unknown
- 1999-07-15 DK DK99934698T patent/DK1098898T3/da active
- 1999-07-15 PL PL99345620A patent/PL195736B1/pl unknown
- 1999-07-15 CN CNB998108383A patent/CN1188422C/zh not_active Expired - Lifetime
- 1999-07-15 EP EP99934698A patent/EP1098898B1/fr not_active Expired - Lifetime
- 1999-07-15 CZ CZ20010219A patent/CZ300447B6/cs not_active IP Right Cessation
- 1999-07-15 AP APAP/P/2001/002039A patent/AP2001002039A0/en unknown
- 1999-07-15 KR KR1020017000740A patent/KR100694721B1/ko not_active Expired - Lifetime
- 1999-07-15 OA OA1200100016A patent/OA11706A/fr unknown
- 1999-07-15 AU AU50379/99A patent/AU766056B2/en not_active Expired
- 1999-07-15 MY MYPI99002983A patent/MY122323A/en unknown
- 1999-07-15 DE DE69904600T patent/DE69904600T2/de not_active Expired - Lifetime
- 1999-07-15 BR BRPI9912156A patent/BRPI9912156B8/pt not_active IP Right Cessation
- 1999-07-15 ES ES99934698T patent/ES2189450T3/es not_active Expired - Lifetime
- 1999-07-15 AT AT99934698T patent/ATE229964T1/de active
- 1999-07-15 JP JP2000560139A patent/JP3437553B2/ja not_active Expired - Lifetime
- 1999-07-15 PE PE1999000714A patent/PE20000869A1/es not_active Application Discontinuation
- 1999-07-15 HR HR20010046A patent/HRP20010046A2/hr not_active Application Discontinuation
- 1999-07-15 GT GT199900111A patent/GT199900111A/es unknown
- 1999-07-15 US US09/744,051 patent/US6514953B1/en not_active Expired - Lifetime
- 1999-07-15 IL IL14082499A patent/IL140824A/en not_active IP Right Cessation
- 1999-07-15 EP EP02013136A patent/EP1240903A3/fr not_active Withdrawn
- 1999-07-15 TR TR2001/00111T patent/TR200100111T2/xx unknown
- 1999-07-15 EA EA200100053A patent/EA003191B1/ru not_active IP Right Cessation
- 1999-07-15 HU HU0103432A patent/HU229700B1/hu unknown
- 1999-07-15 SV SV1999000096A patent/SV1999000096A/es not_active Application Discontinuation
- 1999-07-15 MA MA25684A patent/MA26660A1/fr unknown
- 1999-07-15 JO JO19992114A patent/JO2114B1/en active
- 1999-07-15 NZ NZ509291A patent/NZ509291A/en not_active IP Right Cessation
- 1999-07-15 GE GEAP19995716A patent/GEP20033030B/en unknown
- 1999-07-15 SK SK76-2001A patent/SK285311B6/sk not_active IP Right Cessation
- 1999-07-15 CO CO99044882A patent/CO5090836A1/es unknown
- 1999-07-15 ID IDW20010145A patent/ID28070A/id unknown
- 1999-07-15 CA CA2337857A patent/CA2337857C/fr not_active Expired - Lifetime
- 1999-07-15 TN TNTNSN99145A patent/TNSN99145A1/fr unknown
- 1999-07-15 PT PT99934698T patent/PT1098898E/pt unknown
- 1999-07-15 YU YU3401A patent/YU3401A/sh unknown
- 1999-07-15 WO PCT/EP1999/004991 patent/WO2000004033A1/fr not_active Ceased
- 1999-07-16 PA PA19998477801A patent/PA8477801A1/es unknown
- 1999-08-06 TW TW088113428A patent/TWI245770B/zh not_active IP Right Cessation
2001
- 2001-01-12 IS IS5808A patent/IS5808A/is unknown
- 2001-01-15 ZA ZA200100417A patent/ZA200100417B/en unknown
- 2001-01-17 NO NO20010282A patent/NO329676B1/no not_active IP Right Cessation
- 2001-02-14 BG BG105253A patent/BG105253A/xx unknown
2002
- 2002-11-25 US US10/303,366 patent/US20030096795A1/en not_active Abandoned
- 2002-11-25 US US10/303,213 patent/US20030100537A1/en not_active Abandoned

Also Published As

Publication number	Publication date
GEP20033030B (en)	2003-07-25
AR019388A1 (es)	2002-02-13
TNSN99145A1 (fr)	2005-11-10
EA003191B1 (ru)	2003-02-27
IL140824A0 (en)	2002-02-10
PL195736B1 (pl)	2007-10-31
HUP0103432A2 (hu)	2002-04-29
NZ509291A (en)	2003-05-30
GB9815567D0 (en)	1998-09-16
AU766056B2 (en)	2003-10-09
IL140824A (en)	2004-09-27
JO2114B1 (en)	2000-05-21
AP2001002039A0 (en)	2001-03-31
CA2337857A1 (fr)	2000-01-27
JP3437553B2 (ja)	2003-08-18
HK1034261A1 (en)	2001-10-19
PL345620A1 (en)	2002-01-02
TR200100111T2 (tr)	2002-02-21
HUP0103432A3 (en)	2003-01-28
CN1188422C (zh)	2005-02-09
CA2337857C (fr)	2011-01-25
NO329676B1 (no)	2010-11-29
EP1240903A3 (fr)	2003-02-12
YU3401A (sh)	2005-06-10
EP1098898B1 (fr)	2002-12-18
NO20010282L (no)	2001-03-07
EE200100038A (et)	2002-06-17
KR100694721B1 (ko)	2007-03-15
IS5808A (is)	2001-01-12
BR9912156A (pt)	2001-04-10
EP1098898A1 (fr)	2001-05-16
DE69904600T2 (de)	2003-11-13
EP1240903A2 (fr)	2002-09-18
DZ2845A1 (fr)	2003-12-01
US20030096795A1 (en)	2003-05-22
BRPI9912156B1 (pt)	2016-07-26
OA11706A (en)	2005-01-13
US6514953B1 (en)	2003-02-04
ES2189450T3 (es)	2003-07-01
KR20010071952A (ko)	2001-07-31
US20030100537A1 (en)	2003-05-29
ZA200100417B (en)	2002-02-27
PT1098898E (pt)	2003-04-30
GC0000105A (en)	2005-06-29
CZ2001219A3 (cs)	2001-07-11
DE69904600D1 (de)	2003-01-30
CO5090836A1 (es)	2001-10-30
CN1324363A (zh)	2001-11-28
TWI245770B (en)	2005-12-21
ID28070A (id)	2001-05-03
BRPI9912156B8 (pt)	2021-05-25
CZ300447B6 (cs)	2009-05-20
SV1999000096A (es)	2000-07-06
JP2003521447A (ja)	2003-07-15
NO20010282D0 (no)	2001-01-17
GT199900111A (es)	2001-01-05
SK762001A3 (en)	2001-10-08
EA200100053A1 (ru)	2001-08-27
WO2000004033A1 (fr)	2000-01-27
PE20000869A1 (es)	2000-09-08
MY122323A (en)	2006-04-29
BG105253A (en)	2001-12-29
AU5037999A (en)	2000-02-07
MA26660A1 (fr)	2004-12-20
PA8477801A1 (es)	2000-05-24
HRP20010046A2 (en)	2002-02-28
SK285311B6 (sk)	2006-10-05
ATE229964T1 (de)	2003-01-15
HU229700B1 (en)	2014-05-28

Publication	Publication Date	Title
DK1098898T3 (da)	2003-04-07	Calcium-(3S)-tetrahydro-3-furanyl-(1S,2R)-3-[[(4-aminophenyl)-sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy)propylcarbamat
ATE289212T1 (de)	2005-03-15	Phiole für implantat
ITMI982247A0 (it)	1998-10-20	Procedimento per impermeabilizzare la pelle ottenuta mediante tale procedimento
NO995589L (no)	1999-11-15	Fremgangsmåte for å bestemme senderetning, samt radiosystem
DE69823313D1 (de)	2004-05-27	Instrument-anordnung zur geburtshilfe
ATE189812T1 (de)	2000-03-15	1-alpha, 26-dihydroxy-d-homo-vitamin d3
ATE198886T1 (de)	2001-02-15	Pestizide schwefelverbindungen.
DE59806274D1 (de)	2002-12-19	Anordnung zur übertragung von programmen
DE69804774D1 (de)	2002-05-16	Neutral-gealterte, hydrophobische organosilikat-modifizierte kieselsäuregele
BR9603540A (pt)	1998-05-12	n-metil-n-((1s)-2-((3s)-3-hidróxl-pirrolidin-1-il)etil)-2,2-difenilacetamida
AU5818100A (en)	2001-01-31	Derivatives of (3s) tetrahydro-3-furanyl (1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzy -2-(phosphonooxy)propylcarbamate
SI1098898T1 (en)	2003-08-31	Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3-(((4-aminophenyl) sulfonyl) (isobutyl) amino) -1-benzyl-2- (phosphonooxy) propylcarbamate
AUPP265298A0 (en)	1998-04-23	Simulated illumination of planar, two dimensional shapes
WO2004091280A3 (fr)	2005-02-17	Compositions pharmaceutiques
ITBO980069A0 (it)	1998-02-11	Piattaforma rotante per autoveicoli.
SE9802165D0 (sv)	1998-06-17	Visarinstrument för fordon
SE9802093D0 (sv)	1998-06-12	Farthållare för bilar
HN1999000113A (es)	2001-01-08	(3s) tetrahidro - 3 - funaril (15, 2r) - 3 - [[4 - aminofenil) sulfonil)] (isobutil) amino] - 1 - bencil - 2 (fosfonooxi) propilcarbamato de calcio.
KR970023050U (ko)	1997-06-18	부품 공용화가 용이한 차량 센터 필러
ES1031085Y (es)	1996-05-01	Helicoptero de juguete.
ES1041023Y (es)	1999-10-01	Bandejas de carton.
UA2710S (uk)	1999-04-30	Ковпачок до флаконів
IT1292786B1 (it)	1999-02-11	Dispositivo di pilotaggio per fanali di autoveicolo.